THTahir Hussain

Tahir Hussain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tahir Hussain has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Athar H. Siddiqui

    Heart and Kidney Institute, College of Pharmacy, University of Houston, Houston, TX 77204-5037, USA

    3 shared publications
  • Rifat Sabuhi

    Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, Texas, USA

    3 shared publications
  • Mohammad Asghar

    Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, Texas; and

    2 shared publications
  • Mustafa F. Lokhandwala

    Heart and Kidney Institute, College of Pharmacy, University of Houston, Houston, Texas 77204

    2 shared publications
  • Quaisar Ali

    Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, Texas; and

    2 shared publications
  • Anees Ahmad Banday

    Heart and Kidney Institute, College of Pharmacy, University of Houston, TX 77204, USA

    1 shared publication

Latest Publications

  • Potential Dopamine-1 Receptor Stimulation in Hypertension Management

    by Mohammad Asghar, Seyed K. Tayebati, Mustafa F. Lokhandwala, Tahir Hussain

    The role of dopamine receptors in blood pressure regulation is well established. Genetic ablation of both dopamine D1-like receptor subtypes (D1, D5) and D2-like receptor subtypes (D2, D3, D4) results in a hypertensive phenotype in mice. This review focuses on the dopamine D1-like receptor subtypes D1 and D5 (especially D1 receptors), as they play a major role in regulating sodium homeostasis and blood pressure. Studies mostly describing the role of renal dopamine D1-like receptors are included, as the kidneys play a pivotal role in the maintenance of sodium homeostasis and the long-term regulation of blood pressure. We also attempt to describe the interaction between D1-like receptors and other proteins, especially angiotensin II type 1 and type 2 receptors, which are involved in the maintenance of sodium homeostasis and blood pressure. Finally, we discuss a new concept of renal D1 receptor regulation in hypertension that involves oxidative stress mechanisms.


  • Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats

    by Rifat Sabuhi, Quaisar Ali, Mohammad Asghar, Najah Riesh Hadi Al-Zamily, Tahir Hussain

    Inflammation and oxidative stress are believed to contribute to hypertension in obesity/diabetes. Recently, we reported a role for the AT2 receptor in blood pressure control in obese Zucker rats. However, the role of AT2 receptors in inflammation and oxidative stress in obesity is not known. Therefore, in the present study, we tested the effects of the AT2 receptor agonist CGP-42112A on inflammation and oxidative stress in obese Zucker rats and compared them in their lean counterparts. Rats were systemically treated with either vehicle (control) or CGP-42112A (1 μg·kg−1·min−1; osmotic pump) for 2 wk. Markers of inflammation (CRP, MCP-1, TNF-α, and IL-6) and oxidative stress (HO-1, gp-91phox) as well as an antioxidant (SOD) were determined. Control obese rats had higher plasma levels of CRP, MCP-1, TNF-α, IL-6, and HO-1 compared with control lean rats. Conversely, plasma SOD activity was lower in control obese than in control lean rats. Furthermore, the protein levels of TNF-α and gp-91phox were higher in the kidney cortex of control obese rats. Interestingly, CGP-42112A treatment in obese rats reduced the plasma and kidney cortex inflammatory (TNF-α, IL-6) and oxidative stress (gp-91phox) markers and increased plasma SOD activity to the levels seen in lean control rats. However, CGP-42112A treatment in lean rats increased inflammatory (TNF-α, IL-6) and oxidative stress (gp-91phox) markers in the plasma and kidney cortex. Our present studies suggest anti-inflammatory and antioxidative functions of AT2 receptor in obese Zucker rats but proinflammatory and prooxidative functions in lean Zucker rats.


  • Inhibition of NAD(P)H oxidase potentiates AT2 receptor agonist-induced natriuresis in Sprague-Dawley rats

    by Rifat Sabuhi, Mohammad Asghar, Tahir Hussain

    A positive association between renin-angiotensin system, especially AT1 receptor, and oxidative stress in the pathogenesis of hypertension and cardiovascular/renal diseases has been suggested. However, the role of oxidative stress, especially superoxide radicals in renal sodium handling in response to AT1 and AT2 receptors, is not known. Therefore, the present study was designed to investigate the role of NAD(P)H oxidase (NOX), a major superoxide radical producing enzyme, in AT1 and AT2 receptor function on natriuresis/diuresis in Sprague-Dawley rats. The rats under anesthesia were intravenously infused with NOX inhibitor apocynin (3.5 μg·kg−1·min−1), the AT1 receptor antagonist candesartan (100 μg/kg; bolus), and the AT2 receptor agonist CGP-42112A (1 μg·kg−1·min−1) alone and in combinations. Candesartan alone significantly increased urinary flow (UF; μl/30 min) by 53 and urinary Na excretion (UNaV; μmol/min) by 0.4 over basal. Preinfusion of apocynin had no effect on the net increase in UF or UNaV in response to candesartan. On the other hand, apocynin preinfusion caused profound increases in CGP-42112A-induced UF by 72, UNaV by 1.14, and fractional excretion of Na by 7.8. Apocynin and CGP-42112A alone did not cause significant increase in UF or UNaV over the basal. CGP-42112A infusion in the presence of apocynin increased urinary nitrite/nitrates and cGMP over basal. The infusion of candesartan, apocynin, and CGP-42112A alone or in combinations had no effect on the blood pressure or the glomerular filtration rate, suggesting tubular effects on natriuresis/diuresis. The data suggest that NOX may have an antagonistic role in AT2 receptor-mediated natriuresis/diuresis possibly via neutralizing nitric oxide and thereby influence fluid-Na homeostasis.


  • High glucose up-regulates angiotensin II subtype 2 receptors via interferon regulatory factor-1 in proximal tubule epithelial cells

    by Quaisar Ali, Rifat Sabuhi, Tahir Hussain

    Earlier studies have reported an increase in the proximal tubule AT2 receptor (AT2R) expression in diabetes, with a beneficial role in kidney function and blood pressure regulation. Here, we demonstrate that the increase in AT2R protein expression is associated with an increased expression of transcription factor IRF-1 in hyperglycemic rat and in high glucose-treated HK2 cells. Knock-down of IRF-1 by siRNA in HK2 cells prevented high glucose-induced AT2R up-regulation. The data suggest that IRF-1 is a transcriptional regulator of AT2R expression in hyperglycemia, and warrant further studies to understand the physiological role of IRF-1 along with AT2R in diabetic kidney.


  • Protective Role of Angiotensin II Subtype 2 Receptor in Blood Pressure Increase in Obese Zucker Rats

    by Athar H. Siddiqui, Quaisar Ali, Tahir Hussain

    Earlier, we reported that there was an increase in angiotensin II type 2 (AT2) receptor expression in the renal proximal tubule, and selective activation of the AT2receptor by AT2agonist inhibits Na,K-ATPase activity in the proximal tubules and increases urinary Na excretion in obese Zucker rats. We hypothesized that the AT2receptor has a protective role against blood pressure increase in obese Zucker rats. To test this hypothesis, we treated obese Zucker rats with the AT2receptor antagonist PD123319 (PD; 30 μg/kg per minute) using osmotic pumps. Age-matched lean rats and vehicle-treated obese Zucker rats served as controls. On day 15 of the treatment with PD, arterial blood pressure was measured by cannulation of the left carotid artery under anesthesia. Control obese rats exhibited higher mean arterial pressure (122.0±3.4 mm Hg) compared with lean control rats (97.0±4.8 mm Hg). The PD treatment of obese rats raised mean arterial pressure further by 13 mm Hg. The plasma renin activity was significantly increased in the PD-treated obese compared with control-obese or lean rats. Western blot analysis revealed that the PD treatment in obese rats caused an ≈3-fold increase in the renin expression in the kidney cortex but had no effect on the expression of the cortical angiotensin II type 1 and AT2receptors. The present study suggests that the renal AT2receptors provide a protective role against blood pressure increase in obese Zucker rats, and this protective effect, in part, could be because of the ability of the AT2receptors to keep the kidney renin expression low in obese rats.


  • Impaired Angiotensin II AT1Receptor Function and Enhanced Na, K-ATPase Affinity for Sodium in Proximal Tubule of Streptozotocin-Treated Diabetic Rats

    by Athar H. Siddiqui, Tahir Hussain

    We determined angiotensin II (Ang II) AT1 receptor function in terms of Na-K-ATPAse (NKA) stimulation in the proximal tubule (PTs) of streptozotocin-induced diabetic rats. Ang II (10 pM) stimulated NKA activity in PTs of control rats but not diabetic rats. The AT1 receptor expression was similar, but the expression of G-proteins (Giα2 and Giα3) in the PTs was decreased in diabetic compared with control rats. Kinetic studies revealed an increase in NKA affinity, low K0.5, for Na, with no changes in Vmax of the enzyme in diabetic compared with control rats. Basal Ser-phosphorylation of NKA α1‐subunit was lower in diabetic compared with control rats. This data suggest that the higher basal NKA affinity for Na, possibly due to lower Ser-phosphorylaion of α1-subunit and not the AT1 receptor function, in the PTs may be responsible for increased renal Na reabsorption associated with early stage of streptozotocin-induced diabetes.


  • Enhanced Angiotensin II-Induced Activation of Na+, K+-ATPase in the Proximal Tubules of Obese Zucker Rats

    by Sonal Shah, Tahir Hussain

    Renal angiotensin II (AII) is suggested to play a role in the enhanced sodium reabsorption that causes a shift in pressure natriuresis in obesity related hypertension; however, the mechanism is not known. Therefore, to assess the influence of AII on tubular sodium transport, we determined the effect of AII on the Na+, K+-ATPase activity (NKA), an active transporter regulated by the AT1 receptor activity, in the isolated proximal tubules of lean and obese Zucker rats. Also, we determined the levels of the tubular AT1 receptor and associated signal transducing G proteins, as the initial signaling components that mediate the effects of AII on Na+, K+-ATPase activity. In the isolated proximal tubules, AII produced greater stimulation of the NKA activity in obese compared with lean rats. Determination of the AT1 receptors by Scatchard analysis of the [125I] Sar-Ang II binding and Western blot analysis in the basolateral (BLM) and brush border membrane (BBM) revealed a modest but significant increase (23%) in the AT1 receptor number mainly in the BLM of obese compared with lean rats. The AII affinity for AT1 receptors, as determined by IC50 values of AII to displace [125I] Sar-Ang II binding in BLM and BBM were similar in lean and obese rats. Western blot analysis revealed significant increases in Giα1, Giα2, Giα3, and Gq/11α in BLM and Giα1, Giα3, and Gq/11α in BBM of obese as compared with lean rats. The increase in the levels of the AT1 receptor and G proteins, mainly in the BLM, may be contributing to the enhanced AII-induced activation of NKA in the proximal tubules of obese rats. This phenomenon, in part, may be responsible for the increased sodium reabsorption and the development of hypertension in obese Zucker rats.


  • Open Access

    Insulin treatment enhances AT1receptor function in OK cells

    by Anees Ahmad Banday, Athar H. Siddiqui, Michelle M. Menezes, Tahir Hussain

    Increased renal sodium retention is considered a major risk factor contributing to hypertension associated with chronic hyperinsulinemia and obesity. However, the molecular mechanism involved is not understood. The present study investigates the effect of insulin treatment on AT1receptor expression and ANG II-induced stimulation of Na/H exchanger (NHE) and Na-K-ATPase (NKA) in opossum kidney (OK) cells, a proximal tubule cell line. The presence of the AT1receptors in OK cells was confirmed by the specific binding of125I-sar-ANG II and by detecting ∼43-kDa protein on Western blot analysis with AT1receptor antibody and blocking peptide as well as by expression of AT1receptor mRNA as determined by RT-PCR. Insulin treatment (100 nM for 24 h) caused an increase in125I-sar-ANG II binding, AT1receptor protein content, and mRNA levels. The whole cell lysate and membrane showed similar insulin-induced increase in the AT1receptor protein expression, which was blocked by genistein (100 nM), a tyrosine kinase inhibitor, and cycloheximide (1.5 μg/ml), a protein synthesis inhibitor. Determination of ethyl isopropyl amiloride-sensitive22Na+uptake, a measure of the NHE activity, revealed that ANG II (1–100 pM)-induced stimulation of NHE in insulin-treated cells was significantly greater than in the control cells. Similarly, ANG II (1–100 pM)-induced stimulation of ouabain-sensitive86Rb+uptake, a measure of NKA activity in insulin-treated cells, was significantly greater than in the control cells. ANG II stimulation of both the transporters was blocked by AT1receptor antagonist losartan, suggesting the involvement of AT1receptors. Thus chronic insulin treatment causes upregulation of AT1receptors, which evoked ANG II-induced stimulation of NHE and NKA. We propose that insulin-induced increase in the renal AT1receptor function serves as a mechanism responsible for the increased renal sodium reabsorption and thus may contribute to development of hypertension in conditions associated with hyperinsulinemia.


  • Renal Angiotensin II Receptors, Hyperinsulinemia, and Obesity

    by Tahir Hussain

    Angiotensin II, via activation of AT1 receptors in the kidney regulates sodium/fluid homeostasis and blood pressure. An exaggerated action of angiotensin II mediated via activation of AT1 receptors has been implicated in the increased renal sodium retention and the resetting of the pressure natriuresis in obesity related hypertension. Treatment of obese Zucker rats with AT1 receptor blockers reduces blood pressure to a greater extent and produces greater natriuresis. Also, there is an increased membranal AT1 receptor numbers and angiotensin II produces greater activation of sodium transporters in the isolated tubules from obese Zucker rats. Interestingly, AT2 receptors, which are believed to be beneficial to the renal and cardiovascular function in terms of their action on kidney and blood vessels, are greatly increased in proximal tubular membranes of obese Zucker rats. Whole animal and in vitro studies indicate that higher plasma insulin level, generally associated with obesity, is responsible for the up‐regulation of both AT1 and AT2 receptors in the kidney. Determining the consequence of selective blocking of AT1 receptors and/or activation of the AT2 receptors on renal and cardiovascular function, and the effect of lowering insulin on these receptors present an important area of further investigation in obesity.


  • Rosiglitazone treatment restores renal dopamine receptor function and lowers blood pressure in obese Zucker rats

    by Dhananjay N. Umrani, Tahir Hussain, Mustafa F. Lokhandwala

    We have recently reported that a defective dopamine D1-receptor function leading to the failure of dopamine to inhibit Na,K-ATPase and Na,H-exchanger in proximal tubules may cause sodium retention and contribute to hypertension observed in obese Zucker rats (Hypertension 34:1091-1096, 1999). The present study was designed to test the hypothesis that the defect in D1-receptor function is a result of hyperinsulinemia seen in obese Zucker rats. We designed experiments to study D1-receptor function in obese Zucker rats treated with rosiglitazone as it lowers plasma insulin by improving insulin sensitivity. A group of untreated lean and obese Zucker rats served as control. We found that rosiglitazone treatment (10 mg/kg, p.o. for 4 weeks) caused significant decreases in plasma insulin, blood glucose and blood pressure while increasing 24 hour renal sodium excretion in obese-treated in comparison with obese-untreated Zucker rats. In the isolated renal proximal tubules obtained from untreated lean Zucker rats, dopamine caused concentration-dependent inhibition of Na,K-ATPase and Na,H-exchanger activities but this inhibitory effect was almost blunted in untreated obese Zucker rats. Interestingly, in rosiglitazone-treated obese Zucker rats, the inhibitory effect of dopamine on Na,K-ATPase and Na,H-exchanger activities was similar to that observed in lean Zucker rats. This was accompanied by a similar restoration in renal D1-receptor numbers in treated obese Zucker rats. We propose that there exists an interaction between increased plasma insulin and renal D1-receptors in obese Zucker rats. The restoration of renal D1-receptor function by lowering plasma insulin levels with rosiglitazone may have contributed to the increase in sodium excretion and lowering of blood pressure in obese Zucker rats.